Insoluble Aggregates and Protease-resistant Conformers of Prion Protein in Uninfected Human Brains*

Aggregated prion protein (PrPSc), which is detergent-insoluble and partially proteinase K (PK)-resistant, constitutes the major component of infectious prions that cause a group of transmissible spongiform encephalopathies in animals and humans. PrPSc derives from a detergent-soluble and PK-sensitive cellular prion protein (PrPC) through an α-helix to β-sheet transition. This transition confers on the PrPSc molecule unique physicochemical and biological properties, including insolubility in nondenaturing detergents, an enhanced tendency to form aggregates, resistance to PK digestion, and infectivity, which together are regarded as the basis for distinguishing PrPSc from PrPC. Here we demonstrate, using sedimentation and size exclusion chromatography, that small amounts of detergent-insoluble PrP aggregates are present in uninfected human brains. Moreover, PK-resistant PrP core fragments are detectable following PK treatment. This is the first study that provides experimental evidence supporting the hypothesis that there might be silent prions lying dormant in normal human brains.

[1]  R. Castellani,et al.  Classification of sporadic Creutzfeldt-Jakob disease revisited. , 2006, Brain : a journal of neurology.

[2]  X. Roucou,et al.  Molecular morphology and toxicity of cytoplasmic prion protein aggregates in neuronal and non‐neuronal cells , 2006, Journal of neurochemistry.

[3]  S. Chin,et al.  Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. , 2005, The American journal of pathology.

[4]  Eric D. Ross,et al.  Prion domains: sequences, structures and interactions , 2005, Nature Cell Biology.

[5]  Patrick Tremblay,et al.  Prion clearance in bigenic mice. , 2005, The Journal of general virology.

[6]  G. J. Raymond,et al.  The most infectious prion protein particles , 2005, Nature.

[7]  Ken Chen,et al.  Chronic Wasting Disease of Elk: Transmissibility to Humans Examined by Transgenic Mouse Models , 2005, The Journal of Neuroscience.

[8]  E. Masliah,et al.  Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie , 2005, Science.

[9]  J. Castilla,et al.  In Vitro Generation of Infectious Scrapie Prions , 2005, Cell.

[10]  E. M. Jones,et al.  Fibril Conformation as the Basis of Species- and Strain-Dependent Seeding Specificity of Mammalian Prion Amyloids , 2005, Cell.

[11]  J. Weissman,et al.  Mechanism of Cross-Species Prion Transmission An Infectious Conformation Compatible withTwo Highly Divergent Yeast Prion Proteins , 2005, Cell.

[12]  T. Wisniewski,et al.  Biochemical Fingerprints of Prion Infection: Accumulations of Aberrant Full-Length and N-Terminally Truncated PrP Species Are Common Features in Mouse Prion Disease , 2005, Journal of Virology.

[13]  Charles Weissmann,et al.  The state of the prion , 2004, Nature Reviews Microbiology.

[14]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[15]  Fred E. Cohen,et al.  Evidence for assembly of prions with left-handed β-helices into trimers , 2004 .

[16]  W. Surewicz,et al.  The Effect of Disease-associated Mutations on the Folding Pathway of Human Prion Protein* , 2004, Journal of Biological Chemistry.

[17]  W. Surewicz,et al.  Molecular basis of barriers for interspecies transmissibility of mammalian prions. , 2004, Molecular cell.

[18]  D. Hall,et al.  Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection. , 2004, Journal of molecular biology.

[19]  Shu G. Chen,et al.  Antibody to DNA detects scrapie but not normal prion protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Lisanti,et al.  The Caveolin genes: from cell biology to medicine , 2004, Annals of medicine.

[21]  M. Cox,et al.  The single-stranded DNA-binding protein of Deinococcus radiodurans , 2004, BMC Microbiology.

[22]  H. Ogata,et al.  Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum , 2004, BMC Microbiology.

[23]  Shu G. Chen,et al.  Identification of Novel Proteinase K-resistant C-terminal Fragments of PrP in Creutzfeldt-Jakob Disease* , 2003, Journal of Biological Chemistry.

[24]  Ralf Masuch,et al.  Formation of Critical Oligomers Is a Key Event during Conformational Transition of Recombinant Syrian Hamster Prion Protein* , 2003, Journal of Biological Chemistry.

[25]  S. Prusiner,et al.  Cytosolic Prion Protein in Neurons , 2003, The Journal of Neuroscience.

[26]  R. S. Stewart,et al.  Mutant PrP Is Delayed in Its Exit from the Endoplasmic Reticulum, but Neither Wild-type nor Mutant PrP Undergoes Retrotranslocation Prior to Proteasomal Degradation* , 2003, Journal of Biological Chemistry.

[27]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[28]  W. Surewicz,et al.  Kinetic Intermediate in the Folding of Human Prion Protein* , 2002, The Journal of Biological Chemistry.

[29]  S. Lindquist,et al.  Conversion of PrP to a Self-Perpetuating PrPSc-like Conformation in the Cytosol , 2002, Science.

[30]  G. Friedlander,et al.  Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. , 2002, Biochemistry.

[31]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[32]  Tong Liu,et al.  Heterogeneity of normal prion protein in two‐dimensional immunoblot: presence of various glycosylated and truncated forms , 2002, Journal of neurochemistry.

[33]  Isolation and characterization of a polymerized prion protein. , 2002, The Biochemical journal.

[34]  David A Agard,et al.  Structural studies of the scrapie prion protein by electron crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Witold K. Surewicz,et al.  Crystal structure of the human prion protein reveals a mechanism for oligomerization , 2002, Nature Structural Biology.

[36]  S. Lindquist,et al.  Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Albert Taraboulos,et al.  Proteasomes and ubiquitin are involved in the turnover of the wild‐type prion protein , 2001, The EMBO journal.

[38]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[39]  Fred E. Cohen,et al.  Folding of Prion Protein to Its Native α-Helical Conformation Is under Kinetic Control* , 2001, The Journal of Biological Chemistry.

[40]  W. Surewicz,et al.  On the Mechanism of α-Helix to β-Sheet Transition in the Recombinant Prion Protein† , 2001 .

[41]  I. Taylor,et al.  Preferential binding of fd gene 5 protein to tetraplex nucleic acid structures. , 2000, Journal of molecular biology.

[42]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Pergami,et al.  Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation. , 1999, Biochemical and biophysical research communications.

[44]  S. Krasemann,et al.  Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy. , 1999, Journal of biotechnology.

[45]  A. Buschmann,et al.  Cellular prion proteins of mammalian species display an intrinsic partial proteinase K resistance. , 1998, Biochemical and biophysical research communications.

[46]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[47]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[48]  F. Cohen,et al.  Physical studies of conformational plasticity in a recombinant prion protein. , 1997, Biochemistry.

[49]  M. Lisanti,et al.  Expression and Characterization of Recombinant Caveolin , 1996, The Journal of Biological Chemistry.

[50]  M. Lisanti,et al.  Oligomeric structure of caveolin: implications for caveolae membrane organization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Teplow,et al.  Truncated Forms of the Human Prion Protein in Normal Brain and in Prion Diseases (*) , 1995, The Journal of Biological Chemistry.

[52]  P. Roller,et al.  Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. , 1994, Biochemistry.

[53]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[55]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[56]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[57]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.

[58]  G. Multhaup,et al.  The major polypeptide of scrapie‐associated fibrils (SAF) has the same size, charge distribution and N‐terminal protein sequence as predicted for the normal brain protein (PrP). , 1986, The EMBO journal.

[59]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[60]  L. Hood,et al.  Purification and structural studies of a major scrapie prion protein , 1984, Cell.

[61]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[62]  S. Prusiner,et al.  Identification of a protein that purifies with the scrapie prion. , 1982, Science.

[63]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.